Cardiol Therapeutics Inc Class A

Yahoo Finance • 2 months ago

Cardiol rises on database lockup for acute myocarditis therapy trial

[Stethoscope] adventtr/E+ via Getty Images * Cardiol Therapeutics (NASDAQ:CRDL [https://seekingalpha.com/symbol/CRDL]) shares up after it announced database lock for a mid-stage trial testing its lead asset, CardiolRx, on myocardial rec... Full story

Yahoo Finance • 2 months ago

Cardiol Therapeutics announces database lock for myocarditis trial

TORONTO - Cardiol Therapeutics Inc. (NASDAQ:CRDL) (TSX:CRDL), a clinical-stage biotechnology company with a current market capitalization of $100.83 million, announced Tuesday the database lock for its Phase II ARCHER trial investigating C... Full story

Yahoo Finance • 3 years ago

Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 P.M. EDT

Oakville, Ontario--(Newsfile Corp. - June 27, 2022) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development of cannabidiol... Full story

Yahoo Finance • 3 years ago

CEO Presenting on the Emerging Growth Conference on May 25 Register Now

MIAMI, May 24, 2022 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of t... Full story